본문 바로가기
KERD
논문KCI 등재

간질성방광염/방광통증후군의 진단과 치료

Diagnosis and Management of Interstitial Cystitis/ Painful Bladder Syndrome

김영호
대한배뇨장애요실금학회 (Korean Continence Society)|2008.12|International Neurourology Journal|제12권 제2호|pp. 99-113

2

조회

0

다운로드

2

인용

0

참고문헌

초록

Abstract

Much has changed in our understanding of the interstitial cystitis/painful bladder syndrome (IC/PBS) over time. The International Continence Society (ICS) prefers the term Painful Bladder Syndrome (PBS) defined as "the complaint of suprapubic pain related to bladder filling, accompanied by other symptoms such as increased daytime and night-time frequency, in the absence of proven urinary infection or other obvious pathology". Interstitial cystitis is a clinical diagnosis primarily based on symptoms of urgency/frequency and pain in the bladder and or pelvis. The pathogenesis of IC is still not completely understood, but it is likely multifactorial. The major etiologic theories include abnormality of the bladder urothelium, bladder mast cell activation, bladder inflammation, and altered bladder innervation. The sensitivity and specificity of urinary markers and the potassium sensitivity test have not been prospectively studied. Antiproliferative factor and Tamm-Horsfall protein are novel tests that may prove to be worthwhile pending future studies. Management includes patient education, dietary and lifestyle counseling, oral therapy, intravesical therapy, and surgery. Recently, the European Society for the Study of Interstitial Cystitis (ESSIC) proposed a new nomenclature and classification system. This article discusses recent data and outlines current concepts of IC/PBS. (J Korean Continence Soc 2008;12:99-113)

참고문헌 (82)

  1. Abrams P, "The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society", Neurourol Urodyn, 21, pp.167~178 (2002)
  2. van de Merwe JP, "Diagnostic criteria, classification, and nomenclature for painful bladder syndrome", interstitial cystitis: an ESSIC proposal, 2008, pp.53, 60~67
  3. Elbadawi AE, "Distinctive ultrastructural pathology of nonulcerative interstitial cystitis: new observations and their potential significance in pathogenesis", Urol Int, 56, pp.137~162 (1996)
  4. Peeker R, "Recruitment, distribution and phenotypes of mast cells in interstitial cystitis", J Urol, 163, pp.1009~1015 (2000)
  5. Parsons CL, "Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis)", J Urol, 145, pp.732~735 (1991)
  6. Anderson JB, "The enigma of interstitial cystitis-an autoimmune disease?", Br J Urol, 63, pp.58~63 (1989)
  7. Saban R, "Mast cell regulation of inflammation and gene-expression during antigen-induced bladder inflammation in the mouse", Physiological Genomics, 7, pp.35~43 (2001)
  8. Rosamilia A, "Bladder microvasculature and the effects of hydrodistention in interstitial cystitis", Urology, 57, pp.132~ (2001)
  9. Gillenwater JY, "Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis. National Institutes of Health, Bethesda, Maryland, August 28-29, 1987", J Urol, 140, pp.203~206 (1988)
  10. Hanno PM, "The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study", J Urol, 161, pp.553~557 (1999)
  11. Parsons CL, "The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis", J Urol, 159, pp.1862~1866 (1998)
  12. Wilkinson DR, "Urinary and serologic markers for interstitial cystitis: an update", Curr Urol Rep, 7, pp.414~422 (2006)
  13. Keller ML, "Measurement of symptoms of interstitial cystitis. a pilot study", Urol Clin North Am, 21, pp.67~71 (1994)
  14. O’Leary MP, "The interstitial cystitis symptom index and problem index", Urology, 49, pp.58~63 (1997)
  15. Parsons CL, "Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity", Urology, 60, pp.573~578 (2002)
  16. Propert KJ, "A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group", J Urol, 163, pp.1434~1439 (2000)
  17. Hanno PM, "The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study", J Urol, 161, pp.553~557 (1999)
  18. Fall M, "Treatment of bladder pain syndrome", interstitial cystitis 2008: can we make evidence-based decisions?, 2008, pp.54, 65~75
  19. Mazurick CA, "Evaluation of repeat daily voiding measures in the national interstitial cystitis data base study", J Urol, 163, pp.1208~1211 (2000)
  20. Parsons CL, "Interstitial cystitis: successful management by increasing urinary voiding intervals", Urology, 37, pp.207~212 (1991)
  21. Markwell SJ, "Physical therapy management of pelvi", perineal and perianal syndromes, 2001, pp.19, 194~199
  22. Mendelowitz F, "Complementary approaches in the management of interstitial cystitis. In Sant GR (ed.) Interstitial Cystitis", pp.235~ (1997), Lippincott-Raven
  23. Koziol JA, "Epidemiology of interstitial cystitis", Urol Clin North Am, 21, pp.7~20 (1994)
  24. Wein AJ, "Targets for therapy of the painful bladder", Urology, 59, pp.68~73 (2002)
  25. Erickson DR, "Changes in urine markers and symptoms after bladder distention for interstitial cystitis", J Urol, 177, pp.556~560 (2007)
  26. Cole EE, "Are patient symptoms predictive of the diagnostic and", or therapeutic value of hydrodistention?, 2005, pp.24, 638~642
  27. Parsons CL, "A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosan polysulfate", J Urol, 150, pp.845~848 (1993)
  28. Nickel JC, "Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis", urology, 65, pp.654~658 (2005)
  29. van Ophoven A, "A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis", J Urol, 172, pp.533~536 (2004)
  30. van Ophoven A, "Long-term results of amitriptyline treatment for interstitial cystitis", J Urol, 174, pp.1837~1840 (2005)
  31. Theoharides TC, "Hydroxyzine therapy for interstitial cystitis", Urology, 49, pp.108~110 (1997)
  32. Sant GR, "A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis", J Urol, 170, pp.810~815 (2003)
  33. Seshadri P, "Cimetidine in the treatment of interstitial cystitis", Urology, 44, pp.614~616 (1994)
  34. Forsell T, "Cyclosporine in severe interstitial cystitis", J Urol, 155, pp.1591~1593 (1996)
  35. Sairanen J, "Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study", J Urol, 174, pp.2235~2238 (2005)
  36. Sasaki K, "Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain", Tech Urol, 7, pp.47~49 (2001)
  37. Hansen HC, "Interstitial cystitis and the potential role of gabapentin", South Med J, 93, pp.238~242 (2000)
  38. Kelly JD, "Clinical response to an oral prostaglandin analogue in patients with interstitial cystitis", Eur Urol, 34, pp.53~56 (1998)
  39. Fleischmann JD, "Clinical and immunological response to nifedipine for the treatment of interstitial cystitis", J Urol, 146, pp.1235~1239 (1991)
  40. Bouchelouche K, "Treatment of interstitial cystitis with montelukast, a leukotriene D4 receptors antagonist", Urology, 57, pp.118~ (2001)
  41. Ueda T, "Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T", J Urol, 164, pp.1917~1920 (2000)
  42. Sant GR, "Standard intravesical therapies for interstitial cystitis", Urol Clin North Am, 21, pp.73~83 (1994)
  43. Rössberger J, "Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome", Scand J Urol Nephrol, 39, pp.73~77 (2005)
  44. Peters K, "The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial", J Urol, 157, pp.2090~2094 (1997)
  45. Peeker R, "Intravesical bacillus Calmette-Guérin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study", J Urol, 164, pp.1912~1916 (2000)
  46. Mayer R, "A randomized controlled trial of intravesical bacillus Calmette-Guérin for treatment refractory interstitial cystitis", J Urol, 173, pp.1186~1191 (2005)
  47. Propert KJ, "Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin?", J Urol, 178, pp.886~890 (2007)
  48. Propert KJ, "Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo", J Urol, 179, pp.552~555 (2008)
  49. Morales A, "Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis", Urology, 49, pp.111~113 (1997)
  50. Porru D, "Result of treatment of refractory interstitial cystitis with intravesical hyaluronic acid", Urol Int, 59, pp.26~29 (1997)
  51. Riedl CR, "Hyaluronan treatment of interstitial cystitis", painful bladder syndrome, 2008, pp.19, 717~721
  52. Lazzeri M, "Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study", J Urol, 164, pp.676~679 (2000)
  53. Payne CK, "Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial", J Urol, 173, pp.1590~1594 (2005)
  54. Parsons CL, "Treatment of interstitial cystitis with intravesical heparin", Br J Urol, 73, pp.504~507 (1994)
  55. Steinhoff G, "The efficacy of chondroitin sulfate in treating interstitial cystitis", Eur Urol, 2, pp.14~16 (2003)
  56. Fraser MO, "Intravesical liposome administration- a novel treatment for hyperactive bladder in the rat", Urology, 61, pp.656~663 (2003)
  57. Wammack R, "Efficacy of oral doxepin and piroxicam treatment for interstitial cystitis", Eur Urol, 41, pp.596~600 (2002)
  58. Leppilahti M, "Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis", Urology, 60, pp.46~51 (2002)
  59. Ghoniem GM, "Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy", World J Urol, 11, pp.178~182 (1993)
  60. Whitmore KE, "Intravesical bupivicaine cocktail in the treatment of interstitial cystitis (abstract). Abstracts of the NIDDK Interstitial Cystitis", Association Scientific Meeting (1995)
  61. Davis EL, "Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial", J Urol, 179, pp.177~185 (2008)
  62. Liu HT, "Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis", Urology, 70, pp.463~468 (2007)
  63. Ahmad I, "Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study", Int Urogynecol J, 19, pp.543~546 (2008)
  64. Smith CP, "Botulinum toxin A has antinociceptive effects in treating interstitial cystitis", Urology, 64, pp.871~875 (2004)
  65. Giannantoni A, "Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup", J Urol, 179, pp.1031~1034 (2008)
  66. Yoshimura N, "Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE)", Urology, 57, pp.116~ (2001)
  67. Fall M, "Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis", Urol Clin North Am, 21, pp.131~139 (1994)
  68. Maher CF, "Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis", J Urol, 165, pp.884~886 (2001)
  69. Comiter CV, "Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study", J Urol, 169, pp.1369~1373 (2003)
  70. Peters KM, "Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis", BJU Int, 93, pp.777~779 (2004)
  71. Steinberg AC, "Bilateral S3 stimulator in patients with interstitial cystitis", Urology, 69, pp.441~443 (2007)
  72. Zabihi N, "Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain", Int Urogynecol J, 19, pp.553~557 (2008)
  73. Peeker R, "Complete transurethral resection of ulcers in classic interstitial cystitis", Int Urogynecol J, 11, pp.290~295 (2000)
  74. Rofeim O, "Use of the neodymium:YAG laser for interstitial cystitis: a prospective study", J Urol, 166, pp.134~136 (2001)
  75. Hohenfellner M, "Surgical treatment of interstitial cystitis in women", Int Urogynecol J, 11, pp.113~119 (2000)
  76. Worth PH, "The treatment of interstitial cystitis by cystolysis with observations on cystoplasty. A review after 7 years", Br J Urol, 52, pp.232~ (1980)
  77. Albers DD, "Long-term results of cystolysis (supratrigonal denervation) of the bladder for intractable interstitial cystitis", J Urol, 139, pp.1205~1206 (1988)
  78. Nielsen KK, "Failure of combined supratrigonal cystectomy and Mainz ileocecocystoplasty in intractable interstitial cystitis: is histology and mast cell count a reliable predictor for the outcome of surgery?", J Urol, 144, pp.255~258 (1990)
  79. Webster GD, "The management of chronic interstitial cystitis by substitution cystoplasty", J Urol, 141, pp.287~291 (1989)
  80. Linn JF, "Treatment of interstitial cystitis: comparison of subtrigonal and supratrigonal cystectomy combined with orthotopic bladder substitution", J Urol, 159, pp.774~778 (1998)
  81. Gershbaum D, "Practice trends for the management of interstitial cystitis", Urology, 57, pp.119~ (2001)
  82. Lotenfoe RR, "Absence of neuropathic pelvic pain and favorable psychological profile in the surgical selection of patients with disabling interstitial cystitis", J Urol, 154, pp.2039~2042 (1995)

관련 논문AI추천

간질성 방광염과 방광통증 증후군의 진단과 치료조현희대한산부인과학회 · Obstetrics & Gynecology Science2009 · 제52권 제10호Clinical Approach to Recurrent Voiding Dysfunction, Dysuria, and Pelvic Pain Persisting for at Least 3 Months김계환, 김수진대한배뇨장애요실금학회 · International Neurourology Journal2022 · 제26권 제3호간질성 방광염에서 염증반응으로 인한 요로점막의 변화배재현, 최훈상대한요로생식기감염학회 · Urogenital Tract Infection2013 · 제8권 제2호Interstitial Cystitis/Bladder Pain Syndrome: A Urologic Mystery조영삼대한배뇨장애요실금학회 · International Neurourology Journal2016 · 제20권 제1호만성전립선염/만성골반통증후군의치료김형지대한배뇨장애요실금학회 · International Neurourology Journal2007 · 제11권 제1호여성 복압성요실금 환자에서 수술적 치료 후 발생한 배뇨장애의 치료길건, 김용웅, 김홍식, 나용길, 설종구, 소성민, 신주현, 육승모, 임재성, 한동석대한배뇨장애요실금학회 · International Neurourology Journal2005 · 제9권 제1호

이 간행물의 다른 논문 (13건)

배뇨반사에서 퓨린수용체의 생리적, 병태생리적 기능김대경pp. 93-98과민성방광 환자에서 Propiverine Hydrochloride 40mg의 효과 및 안전성: 전향적, 다기관, 관찰 연구박철희, 서주태, 김수진, 김하영, 김준철, 조원열, 양상국, 허정식, 이규성, 주명수, 이주환pp. 114-120가토의 고환절제술 후에 변화되는 방광조직 내의 단백질에 대한 단백체학적 분석김형지, 홍주형pp. 121-126의정부 지역 택시기사와 일반 사무직에서의 전립선과 관련된 하부요로증상과 객관적 소견간의 분석강성학, 이동섭, 이용석, 한창희pp. 127-132뇌질환을 동반한 과민성방광 환자에서 tolterodine 투여 후 인지기능의 변화조원열, 김태호, 박민정pp. 133-138
원문 보기